ROCKWELL MEDICAL, INC. (RMTI) Gross margin 2017–2025
ROCKWELL MEDICAL, INC. (RMTI) gross margin by fiscal year — reported gross profit divided by reported revenue.
16.9%FY2025 · since FY2017: 6.5% → 16.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 16.9% | -0.3 pp |
| FY2024 | 17.2% | +6.8 pp |
| FY2023 | 10.4% | +4.8 pp |
| FY2022 | 5.6% | +9.5 pp |
| FY2021 | -3.9% | -8.3 pp |
| FY2020 | 4.4% | -0.2 pp |
| FY2019 | 4.6% | +7.1 pp |
| FY2018 | -2.5% | -9.0 pp |
| FY2017 | 6.5% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More RMTI financial trends
RMTI RevenueRMTI Net incomeRMTI Net marginRMTI Gross profitRMTI Operating incomeRMTI Operating marginRMTI Operating cash flowRMTI Free cash flowRMTI Capital expendituresRMTI Return on equityRMTI Stock buybacksRMTI Dividends paidRMTI Total assetsRMTI Total liabilitiesRMTI Shareholders’ equityRMTI overview →